These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3686478)

  • 21. [Agranulocytosis related to fluindione: A case report].
    Ngo S; Benhamou Y; Armengol G; Sauvêtre G; Cailleux-Talbot N; Massy N; Buchonnet G; Lévesque H
    Rev Med Interne; 2016 Jan; 37(1):58-61. PubMed ID: 26096756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute immuno-allergic interstitial nephritis caused by fluindione.
    Belmouaz S; Desport E; Abou Ayache R; Thierry A; Mignot A; Bauwens M; Goujon JM; Bridoux F; Touchard G
    Clin Nephrol; 2006 Dec; 66(6):455-8. PubMed ID: 17176918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Asymptomatic acute cytolytic hepatitis due to fluindione and associated with resistance to treatment: a case report and review of the literature].
    Penot JP; Fontenelle P; Dorleac D
    Arch Mal Coeur Vaiss; 1998 Feb; 91(2):267-70. PubMed ID: 9749256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can colchicine potentiate the anticoagulant effect of fluindione?
    Gras-Champel V; Ohlmann P; Polard E; Wiesel ML; Imbs JL; Andréjak M
    Eur J Clin Pharmacol; 2005 Aug; 61(7):555-6. PubMed ID: 16007421
    [No Abstract]   [Full Text] [Related]  

  • 25. [Interaction between warfarin and oral miconazole gel].
    Ogard CG; Vestergaard H
    Ugeskr Laeger; 2000 Oct; 162(41):5511. PubMed ID: 11068529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anticoagulant treatment with fluindione. Relation between the decrease of vitamin K-dependent factors and blood fluindione].
    Roncato M; Billaud-Mesguich E; Fiessinger JN; Vitoux JF; Aiach M; Alexandre JM
    Therapie; 1986; 41(3):203-6. PubMed ID: 3750259
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influence of long-term anticoagulant treatment on reinfarction, mortality and rehabilitation of patients with myocardial infarct. 4-year-observation ambulatory surveillance of infarction].
    Schubert W
    Z Gesamte Inn Med; 1972 Apr; 27(7):307-11. PubMed ID: 4625900
    [No Abstract]   [Full Text] [Related]  

  • 28. Potentiation of warfarin anticoagulant activity by miconazole oral gel.
    Ariyaratnam S; Thakker NS; Sloan P; Thornhill MH
    BMJ; 1997 Feb; 314(7077):349. PubMed ID: 9040331
    [No Abstract]   [Full Text] [Related]  

  • 29. [The elderly and emergencies. Accidents with anticoagulants].
    Jullien P; Branche G
    Soins Gerontol; 1997 Apr; (7):19-21. PubMed ID: 9275856
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tramadol and oral anticoagulants: interaction or confounding factors?].
    Chiffoleau A; Veyrac G; Dudouet D; Miremont G; Merle L; David-Laroche M; Bourin M; Jolliet P
    Therapie; 2003; 58(5):471-4. PubMed ID: 14682201
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypersensitivity to fluindione (Previscan). Positive skin patch tests].
    Frouin E; Roth B; Grange A; Grange F; Tortel MC; Guillaume JC
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):1000-2. PubMed ID: 16446646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Miconazole-warfarin interaction: increased INR.
    Murty M
    CMAJ; 2001 Jul; 165(1):81-2, 85-6. PubMed ID: 11468962
    [No Abstract]   [Full Text] [Related]  

  • 33. A case of bleeding requiring hospitalization that was likely caused by an interaction between warfarin and levamisole.
    Wehbe TW; Warth JA
    Clin Pharmacol Ther; 1996 Mar; 59(3):360-2. PubMed ID: 8653999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of warfarin's hypoprothrombinemic effect with miconazole vaginal suppositories.
    Thirion DJ; Zanetti LA
    Pharmacotherapy; 2000 Jan; 20(1):98-9. PubMed ID: 10641982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bleeding complications in peroral anticoagulant therapy. A retrospective study of the importance of drug synergism].
    Alexanderson B; Taube A; Westerholm B
    Lakartidningen; 1971 Mar; 68():Suppl I:35+. PubMed ID: 5314654
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fluindione-induced acute generalised exanthematous pustulosis confirmed by patch testing].
    Chtioui M; Cousin-Testard F; Zimmermann U; Amar A; Saiag P; Mahé E
    Ann Dermatol Venereol; 2008 Apr; 135(4):295-8. PubMed ID: 18420077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug interactions between coumarin derivatives and antimycotics: also with topical antifungal agents].
    Jessurun NT; van Puijenbroek EP
    Ned Tijdschr Geneeskd; 2013; 157(4):A5317. PubMed ID: 23343733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting daily maintenance dose of fluindione, an oral anticoagulant drug.
    Cazaux V; Gauthier B; Elias A; Lefebvre D; Tredez J; Nguyen F; Cambus JP; Boneu B; Boccalon H
    Thromb Haemost; 1996 May; 75(5):731-3. PubMed ID: 8725714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients.
    Mentré F; Pousset F; Comets E; Plaud B; Diquet B; Montalescot G; Ankri A; Mallet A; Lechat P
    Clin Pharmacol Ther; 1998 Jan; 63(1):64-78. PubMed ID: 9465843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Esomeprazole-induced resistance to fluindione: An unrecognized interaction].
    Ayme-Dietrich E; Aubertin-Kirch G; Andrès E; Monassier L
    Therapie; 2016 Jun; 71(3):337-41. PubMed ID: 27235659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.